Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
excellent even though I am fairly new
What are some of the best things about your team?
good team approach and lots of resources
What is most positive about the culture and environment at your company?
everyone friendly and willing to help you succeed
What do you like best about the leadership team?
open and transparent good communication
What is the best part about your compensation package?
espp is a great benefit
What makes you most happy at work?
seeing customers and helping patients
Other Employee Reviews for Karyopharm Therapeutics
×